University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio,
暂无分享,去创建一个
Rensburg | A. Whittemore | D. Steinemann | B. Bonanni | O. Olopade | T. Rebbeck | B. Karlan | J. Benítez | R. Eeles | J. Hopper | E. John | M. Southey | D. Easton | K. Offit | A. Antoniou | N. Loman | S. Buys | D. Eccles | H. Nevanlinna | P. Devilee | R. Milne | C. Lázaro | K. Nathanson | J. Garber | Andrew Lee | K. Aittomäki | H. Meijers-Heijboer | A. Meindl | R. Schmutzler | G. Pita | I. Andrulis | G. Glendon | P. Radice | P. Peterlongo | S. Manoukian | C. Asperen | A. Jakubowska | J. Lubiński | K. Durda | S. Slager | J. Simard | S. Neuhausen | C. Sutter | S. Wang-gohrke | D. Yannoukakos | L. McGuffog | A. Godwin | A. Osorio | N. Ditsch | B. Wappenschmidt | S. Domchek | D. Stoppa-Lyonnet | N. Lindor | M. Porteous | A. Viel | D. Frost | O. Sinilnikova | S. Mazoyer | C. Engel | K. Claes | J. Rantala | R. Platte | B. Arun | U. Jensen | F. Damiola | L. Ottini | S. Hodgson | B. Poppe | G. Scuvera | L. Side | L. Sunde | T. Rutherford | T. Hansen | A. Gerdes | F. Lalloo | B. Arver | M. Daly | M. Beattie | K. Kuchenbaecker | M. Thomassen | B. Ejlertsen | J. Lester | T. Cole | C. Cybulski | K. Tucker | A. Bojesen | J. Weitzel | M. Tischkowitz | L. Varesco | K. Kast | K. Rhiem | M. Terry | C. Walsh | B. Peissel | F. Lejbkowicz | P. Morrison | C. Phelan | J. Gronwald | M. Rookus | T. Kruse | L. Izatt | E. Oláh | C. Brewer | R. Davidson | P. Soucy | D. Barrowdale | M. Piedmonte | I. Blanco | T. Caldés | R. Janavicius | S. Ellis | E. Fineberg | J. Adlard | J. Cook | F. Douglas | A. Donaldson | L. Papi | M. Tibiletti | S. Volorio | N. Arnold | A. Gehrig | D. Niederacher | H. Plendl | S. Preisler‐Adams | R. Varon‐Mateeva | L. Jønson | Y. Ding | L. Steele | Á. Teulé | J. Herzog | M. Durán | C. M. Dorfling | M. Hoya | F. Backes | K. Wakeley | L. Walker | I. Konstantopoulou | W. Brewster | L. Guidugli | A. Hout | M. Menéndez | Kisa Weeman | H. Ehrencrona | G. Evans | D. Zaffaroni | R. Alonso | Tereza Vaclová | M. Infante | T. A. Os | T. R. Y. Cajal | F. Mariette | R. Conejero | Claire Foo | A. Lee | B. Herráez | Letícia | C. Martínez‐Bouzas | E. García | C. V. Deurzen | J. Kennedy | E. J. van | Thais Moreno | A. Teule | T. Cole | J. Cook | Radka Platte | Steve Ellis
[1] W. Chung,et al. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.
[2] D. Altshuler,et al. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk , 2013, PLoS genetics.
[3] Wu Wei,et al. Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis , 2012, Molecular Biology Reports.
[4] Xifeng Wu,et al. Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guérin , 2012, PloS one.
[5] A. Tomkinson,et al. Increased risk of lung cancer associated with a functionally impaired polymorphic variant of the human DNA glycosylase NEIL2. , 2012, DNA repair.
[6] A. Antoniou,et al. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers , 2012, Journal of internal medicine.
[7] D. Easton,et al. Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.
[8] Mads Thomassen,et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers , 2012, Breast Cancer Research.
[9] S. Edge,et al. Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. , 2011, Carcinogenesis.
[10] B. Bonanni,et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 , 2011, British Journal of Cancer.
[11] K. Bhakat,et al. Preferential Repair of Oxidized Base Damage in the Transcribed Genes of Mammalian Cells* , 2010, The Journal of Biological Chemistry.
[12] Christiana Kartsonaki,et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.
[13] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[14] T. Seufferlein,et al. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis , 2010, Gut.
[15] P. Brandt-Rauf,et al. XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study , 2010, Journal of carcinogenesis.
[16] C. Rondelli,et al. Regulatory regions responsive to oxidative stress in the promoter of the human DNA glycosylase gene NEIL2. , 2010, Mutagenesis.
[17] Chen-Yang Shen,et al. Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk , 2010, Annals of Surgical Oncology.
[18] Mads Thomassen,et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2009, Human molecular genetics.
[19] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[20] H. Krokan,et al. The rate of base excision repair of uracil is controlled by the initiating glycosylase. , 2008, DNA repair.
[21] S. Z. Abdel‐Rahman,et al. Single nucleotide polymorphisms 5′ upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage , 2008, Genes, chromosomes & cancer.
[22] P. Brennan,et al. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women , 2008, Breast Cancer Research and Treatment.
[23] Hui-Ping Zhao,et al. Functional Variants of the NEIL1 and NEIL2 Genes and Risk and Progression of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx , 2008, Clinical Cancer Research.
[24] F. Couch,et al. Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers , 2008 .
[25] C. Walter,et al. Base excision repair, aging and health span , 2008, Mechanisms of Ageing and Development.
[26] M. Urioste,et al. The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain , 2008, Clinical Cancer Research.
[27] Jiuyong Xie,et al. Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation. , 2008, Carcinogenesis.
[28] Yurii S. Aulchenko,et al. A Genomic Background Based Method for Association Analysis in Related Individuals , 2007, PloS one.
[29] F. Couch,et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.
[30] Georgia Chenevix-Trench,et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.
[31] A. Neugut,et al. OGG1 Polymorphisms and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.
[32] Leif E. Peterson,et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] S. Chanock,et al. Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[34] A. Mes-Masson,et al. OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer. , 2005, International journal of oncology.
[35] J. Chang-Claude,et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.
[36] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[37] Bernard Prum,et al. Estimation of the inbreeding coefficient through use of genomic data. , 2003, American journal of human genetics.
[38] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[39] B. Koller,et al. Brca1 controls homology-directed DNA repair. , 1999, Molecular cell.
[40] B. Ponder,et al. Involvement of Brca2 in DNA repair. , 1998, Molecular cell.
[41] J. Chang-Claude,et al. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk , 2013, International journal of cancer.
[42] O. Delaneau,et al. Haplotype inference. , 2012, Methods in molecular biology.